Aglycosylated Chimeric Mouse/Human IgG1 Antibody Retains Some Effector Function
- 1 April 1991
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 10 (2) , 211-217
- https://doi.org/10.1089/hyb.1991.10.211
Abstract
The N-linked carbohydrate attachment site of human IgG1 Ab has been eliminated by site-directed mutagenesis. Effector functions of aglycosylated Ab was then compared to its native counterpart. Aglycosylated Ab failed to exhibit any ADCC activity, but a significant level of CDC activity was retained by the aglycosylated Ab. These observations differ from those reported previously. Serum half-life and biodistribution of aglycosylated Ab in mice were comparable to the native Ab. Together, these results show that some, but not all, effector functions of a human IgG1 Ab are affected by aglycosylation.Keywords
This publication has 10 references indexed in Scilit:
- Antigen binding and biological activities of engineered mutant chimeric antibodies with human tumor specificitiesHuman Antibodies, 1990
- High-level expression of chimeric antibodies using adapted cDNA variable region cassettesJournal of Immunological Methods, 1989
- Expression of Human Anti-Tetanus Toxoid Antibody in Transfected Murine Myeloma CellsNature Biotechnology, 1989
- Localization of the binding site for the human high-affinity Fc receptor on IgGNature, 1988
- Biological significance of carbohydrate chains on monoclonal antibodies.Proceedings of the National Academy of Sciences, 1983
- [32] Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectorsPublished by Elsevier ,1983
- Three-Dimensional Structure of ImmunoglobulinsAnnual Review of Biochemistry, 1979
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977
- Aglycosylantibody. Effects of exoglycosidase treatments on autochthonous antibody survival time in the circulation.Journal of Biological Chemistry, 1976